SanegeneBio taps Orbit Discovery to generate targeting peptides for RNA therapies 17-Jan-2023 By Nick Taylor SanegeneBio has formed a service agreement with Orbit Discovery to support tissue-specific delivery of a wide range of RNA therapeutics.